Fibroid Awareness Week beginning April 18 centers United States Awareness of uterine leiomyomas impacting Women across reproductive lifespans. The observance amplifies patient advocacy, clinical literacy, and research funding to address symptom burden—menorrhagia, pelvic pressure, and fertility implications—often minimized in primary care. Clinicians host webinars on differential diagnostics, myomectomy vs. UAE decision matrices, and hormone-modulating therapies. It’s data over dismissal. Survivors share histopathology narratives while epidemiologists discuss disparities in diagnosis latency and access. By translating pathologic terminology into actionable screening criteria, the week advances gynecologic autonomy and reframes fibroids from private inconvenience to public health priority.
coming soon